Table 2.
Short follow‐up facility group (four facilities/2495 patients) N (%) | Long follow‐up facility group (four facilities/604 patients) N (%) | |
---|---|---|
Cancer stage | ||
0 | 705 (28.3) | 146 (24.2) |
I | 974 (39.0) | 204 (33.8) |
IIa | 421 (16.9) | 116 (19.2) |
IIb | 175 (7.0) | 55 (9.1) |
III(a,b,c) | 150 (6.0) | 50 (8.3) |
IV | 34 (1.4) | 16 (2.6) |
Missing | 36 (1.4) | 17 (2.8) |